Navigation Links
HIV Drug a Double-Edged Sword for Infants
Date:1/18/2009

Nevirapine protects during breast-feeding, but resistant disease can develop in first year, study shows,,,,

SUNDAY, Jan. 18 (HealthDay News) -- The antiretroviral drug nevirapine may help prevent babies of HIV-positive mothers from getting the virus through breast-feeding, but it also greatly increases the odds of developing drug-resistant HIV if they are infected during the first year of life, a new study finds.

Still, the researchers consider the six-week course of the drug the best alternative available.

Given the higher chance of a baby on nevirapine acquiring treatment-resistant HIV, the authors call for the infants to also receive protease inhibitors (PIs), which can combat nevirapine-resistant HIV strains.

"Until other interventions become available, the extended nevirapine regimen remains a reasonable way to prevent infections through breast-feeding," senior investigator Dr. Deborah Persaud, a pediatric HIV expert at John Hopkins Children's Center, said in a news release issued by the school.

The study, published in the Jan. 1 issue of the Public Library of Science One, noted the treatment is best for HIV-positive mothers in developing countries where bottle feeding is not an alternative because of cost, safety or availability.

HIV infection is estimated to occur in one out of 10 breast-fed infants, most of the time happening in the first 14 weeks of life, according to estimates by the World Health Organization (WHO), which recommends breast-feeding for at least six months despite the known risk of HIV transmission.

Two reports published in 2008 found that a six-week treatment of nevirapine cut the risk of HIV infection from breast-feeding nearly in half, while a 14-week regimen cut it by 66 percent.

More information

The U.S. National Institute of Allergy and Infectious Disease has more about HIV infection in women.



-- Kevin McKeever



SOURCE: Johns Hopkins Children's Center, news release, Jan. 5, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Anemia treatment may be a double-edged sword
2. Cellular senescence a double-edged sword
3. Nicotine in breast milk disrupts infants sleep patterns
4. Shaking may cause brain damage and serious long-term effects to infants
5. Maternal depression and controlling behavior associated with increased stress response in infants
6. Repeat steroids to premature infants linked to cerebral palsy
7. Babies raised in bilingual homes learn new words differently than infants learning one language
8. Research shows how genetic mutation causes epilepsy in infants
9. Combination vaccines okay for infants, study shows
10. $4 million nursing grant focuses on at-risk premature infants
11. McNeil Consumer Healthcare is Voluntarily Withdrawing Infants Cough and Cold Products:
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drug a Double-Edged Sword for Infants
(Date:3/29/2017)... ... March 29, 2017 , ... ... is growing as it continues developing an ANSI-approved, consensus-based American National Standard ... which plans to publish the first ANSI-approved GMP standard for dietary supplements ...
(Date:3/29/2017)... , ... March 29, 2017 , ... HealthCareMandA.com will host ... April 20, 2017, at 1:00 PM ET. A recording of the webinar will also ... Webinar Series. , Home health and hospice companies are still popular targets for healthcare ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... of Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who ... at Intercontinental Time Square, New York. , The program will be led ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... Tuesday, ... asking the American public to take the Diabetes Risk Test to find out if ... the Los Angeles World Airports will light up the evening sky by programming the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Revolution for Truth has organized ... protect parental rights and civil liberties, and to restore transparency within government agencies ... coincides with a press conference taking place Friday morning calling on President Trump ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ("Medicure") ... financial results for the year ended December 31, ... 2017. The results are being released later than ... statements will include the operations and balances of ... 2016.  This release and filing date meets TSX ...
(Date:3/28/2017)... "Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and ... market trends of the Chemotherapy Induced Neutropenia for the seven major ... ( France , Germany ... UK) and Japan , as well as rest ... world (RoW). The Report covers the therapeutics market revenue, ...
(Date:3/28/2017)... , March 28, 2017  "US Cancer ... on the various indicators and trend analysis related ... drugs in mainstream pharmaceutical market in US. The ... for the growth on cancer generics drugs in ... in saving of billions of dollars for various ...
Breaking Medicine Technology: